Atsumi T, Koike T
Department of Internal Medicine II, Hokkaido University School of Medicine.
Nihon Rinsho. 1998 Jan;56(1):215-23.
Antiphospholipid antibodies (aPL) are a family of autoantibodies with specificity for negatively charged phospholipids, or more accurately for their complex to phospholipid binding proteins. Their presence is associated with arterial/venous thrombosis and recurrent pregnancy loss. These clinical manifestations with the persistence of aPL are recognized as antiphospholipid syndrome(APS), one of the most common acquired thrombophilia. beta 2-glycoprotein I(beta 2GPI) bears the epitope(s) for anticardiolipin antibodies (aCL) on its molecule, and lupus anticoagulant activity depends on the presence of beta 2GPI or prothrombin. Thus phospholipid binding proteins may have some crucial roles in the pathophysiology of thrombotic events in APS. It has been hypothesized that aPL bind to cells and induce procoagulant activity via phospholipid binding proteins.
抗磷脂抗体(aPL)是一类对带负电荷的磷脂具有特异性的自身抗体,更准确地说是对其与磷脂结合蛋白的复合物具有特异性。它们的存在与动脉/静脉血栓形成和复发性流产有关。aPL持续存在的这些临床表现被认为是抗磷脂综合征(APS),这是最常见的获得性血栓形成倾向之一。β2糖蛋白I(β2GPI)在其分子上带有抗心磷脂抗体(aCL)的表位,狼疮抗凝活性取决于β2GPI或凝血酶原的存在。因此,磷脂结合蛋白可能在APS血栓形成事件的病理生理学中发挥一些关键作用。据推测,aPL与细胞结合并通过磷脂结合蛋白诱导促凝活性。